Cellebrite DI (CLBT) Total Current Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has reported Total Current Liabilities for 6 consecutive years, with $369.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Current Liabilities rose 25.09% year-over-year to $369.7 million; the TTM figure through Dec 2025 stood at $369.7 million (up 25.09% YoY), while the FY2025 annual figure was $369.7 million, up 25.09% from the prior year.
• Total Current Liabilities came in at $369.7 million for Q4 2025 at Cellebrite DI, up from $316.9 million in the prior quarter.
• The five-year high for Total Current Liabilities was $403.7 million in Q3 2021, with the low at $170.6 million in Q1 2022.
• Average Total Current Liabilities over 5 years is $252.5 million, with a median of $235.9 million recorded in 2024.
• Across the five-year window, Total Current Liabilities plunged 52.99% in 2022 and soared 30.66% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $186.6 million in 2021, then grew by 11.36% to $207.8 million in 2022, then gained by 22.16% to $253.8 million in 2023, then gained by 16.42% to $295.5 million in 2024, then grew by 25.09% to $369.7 million in 2025.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $369.7 million, $316.9 million, and $310.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.